Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Journal of Endotoxin Research
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Araña, M. d. J.
Right arrow Articles by Reyes, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Araña, M. d. J.
Right arrow Articles by Reyes, O.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction

Manuel de J. Araña

Division of Chemistry & Physics, Center for Genetic Engineering and Biotechnology, La Habana, Cuba, manuel.arana{at}cigb.edu.cu

Maribel G. Vallespi

Division of Chemistry & Physics, Center for Genetic Engineering and Biotechnology, La Habana, Cuba

Glay Chinea

Division of Chemistry & Physics, Center for Genetic Engineering and Biotechnology, La Habana, Cuba

Guillermo V. Vallespi

Division of Chemistry & Physics, Center for Genetic Engineering and Biotechnology, La Habana, Cuba

Ingrid Rodriguez-Alonso

Division of Chemistry & Physics, Center for Genetic Engineering and Biotechnology, La Habana, Cuba

Hilda E. Garay

Division of Chemistry & Physics, Center for Genetic Engineering and Biotechnology, La Habana, Cuba

Wim A. Buurman

Department of General Surgery, University of Maastricht, Maastricht, The Netherlands

Osvaldo Reyes

Division of Chemistry & Physics, Center for Genetic Engineering and Biotechnology, La Habana, Cuba

The ability of LPS-binding protein (LBP) to greatly potentiate cell responses to lipopolysaccharide (LPS) may largely contribute to LPS toxicity in sepsis. The study of agents with the capacity to block the interaction between LBP and LPS might improve the understanding of the role of LBP in Gram-negative infections as well as offering new therapeutic tools for septic disorders. Here we confirm the ability of synthetic peptides comprising the human LBP amino acid region 86-108 to interfere with the LBP-LPS interaction. The analysis of selected alanine mutants of a blocking peptide corresponding to the LBP region 86-99 suggests the importance of peptide amphipathicity for the inhibitory activity. The potency of the native peptide and a selected analogue at inhibiting in vitro and in vivo LPS-induced responses was associated with their relative activity in blocking LBP-LPS interaction. It was remarkable that these peptides were at least 500-fold more active in vivo than in vitro. Also, the inhibitory activity of peptides LBP86-99 and LBPK95A seems to be independent of LBP concentrations, a behavior that may be relevant for the potential use of these peptides in septic disorders where LBP serum concentrations are considerably elevated.

Journal of Endotoxin Research, Vol. 9, No. 5, 281-291 (2003)
DOI: 10.1177/09680519030090050301
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?